The Influence of Cisplatin on the Gas-Phase Dissociation of Oligonucleotides Studied by Electrospray Ionization Tandem Mass Spectrometry

Journal of the American Society for Mass Spectrometry

Volumn 20, Issue 5, 2009, Pages 792-804

  Nyakas, Adrien ^a   Eymann, Michael ^a   Schürch, Stefan ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-CANCER DRUGS; ANTI-CANCER THERAPIES; BASE PAIRS; BINDING MOTIFS; CISPLATIN; DISSOCIATION PATHWAYS; ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRIES; GAS-PHASE; GAS-PHASE DISSOCIATIONS; GAS-PHASE FRAGMENTATIONS; MECHANISTIC ASPECTS; MS/MS EXPERIMENTS; OLIGODEOXYNUCLEOTIDES; OLIGORIBONUCLEOTIDES; TANDEM MASS SPECTROMETRIC; TANDEM MASS SPECTROMETRIES;

BINDING ENERGY; BINDING SITES; DISSOCIATION; DRUG THERAPY; ELECTROSPRAY IONIZATION; GASES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IONIZATION OF GASES; MASS SPECTROMETERS; MASS SPECTROMETRY; NUCLEIC ACIDS; OLIGONUCLEOTIDES; POSITIVE IONS; RNA; SPECTRUM ANALYSIS;

PLATINUM COMPOUNDS;

CISPLATIN; GUANINE DERIVATIVE; METHYLPHOSPHONIC ACID; OLIGODEOXYNUCLEOTIDE DERIVATIVE; OLIGONUCLEOTIDE; OLIGORIBONUCLEOTIDE;

ARTICLE; BINDING SITE; CHEMICAL BOND; DRUG BINDING; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY;

CISPLATIN; NUCLEIC ACID CONFORMATION; OLIGODEOXYRIBONUCLEOTIDES; OLIGONUCLEOTIDES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 64049092350     PISSN: 10440305     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jasms.2008.12.018     Document Type: Article

References (71)

1. Rosenberg B., Van Camp L., and Krigas T. Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode. Nature 205 4972 (1965) 698-699
2. Khan A., and Hill J.M. Immunosuppression with Cis-platinum (II) Diamminodichloride-Effect on Antibody Plaque-Forming Spleen Cells. Infect. Immun. 4 3 (1971) 320-321
3. Jamieson E.R., and Lippard S.J. Structure, Recognition, and Processing of Cisplatin-DNA Adducts. Chem. Rev. 99 9 (1999) 2467-2498
4. Reedijk J. New Clues for Platinum Antitumor Chemistry: Kinetically Controlled Metal Binding to DNA. Proc. Natl. Acad. Sci. U.S.A. 100 7 (2003) 3611-3616
5. Rosenberg B. Noble Metal Complexes in Cancer Chemotherapy. Adv. Exp. Med. Biol. 91 (1977) 129-150
6. Wong E., and Giandomenico C.M. Current Status of Platinum-Based Antitumor Drugs. Chem. Rev. 99 9 (1999) 2451-2466
7. Adler H.I., and Hardigree A.A. Postirradiation Growth Division and Recovery in Bacteria. Radiat. Res. 25 1 (1965) 92-102
8. Akaboshi M., Kawai K., Maki H., Akuta K., Ujeno Y., and Miyahara T. The Number of Platinum Atoms Binding to DNA, RNA and Protein Molecules of HELA-Cells treated with Cisplatin at Its Mean Lethal Concentration. Jpn J. Cancer Res. 83 5 (1992) 522-526
9. Haraguchi H. Metallomics as Integrated Biometal Science. J. Anal. At. Spectrom. 19 1 (2004) 5-14
10. Harder H.C. Inhibitory Effects of Anti-Tumor Platinum Compounds on DNA, RNA, and Protein Syntheses in Mammalian Cells In Vitro. Int. J. Cancer 6 2 (1970) 207-216
11. Howle J.A., and Gale G.R. Cis-Dichlorodiammineplatinum (II): Persistent and Selective Inhibition of Deoxyribonucleic Acid Synthesis In Vivo. Biochem. Pharmacol. 19 10 (1970) 2757-2762
12. Pascoe J.M., and Roberts J.J. Interactions Between Mammalian-Cell DNA and Inorganic Platinum Compounds. 1. DNA Interstrand Crosslinking and Cytotoxic Properties of Platinum(II) Compounds. Biochem. Pharmacol. 23 9 (1974) 1345-1357
13. Reslova S. The Induction of Lysogenic Strains of Escherichia coli by Cis-Dichlorodiammineplatinum (II). Chem. Biol. Interact. 4 1 (1971) 66-70
14. Rosenkranz H.S., Garro A.J., Levy J.A., and Carr H.S. Studies with Hydroxyurea. I. The Reversible Inhibition of Bacterial DNA Synthesis and the Effect of Hydroxyurea on the Bactericidal Action of Streptomycin. Biochim. Biophys. Acta 114 3 (1966) 501-515
15. Speelmans G., Sips W., Grisel R.J.H., Staffhorst R., Fichtinger-Schepman A.M.J., Reedijk J., and de Kruijff B. The Interaction of the Anti-Cancer Drug Cisplatin with Phospholipids is Specific for Negatively Charged Phospholipids and Takes Place at Low Chloride Ion Concentration. Biochim. Biophys. Acta Biomembranes 1283 1 (1996) 60-66
16. Speelmans G., Staffhorst R., Versluis K., Reedijk J., and de Kruijff B. Cisplatin Complexes with Phosphatidylserine in membranes. Biochemistry 36 34 (1997) 10545-10550
17. Witkin E.M. The Radiation Sensitivity of Escherichia coli B: a Hypothesis relating Filament Formation and Prophage Induction. Proc. Natl. Acad. Sci. U.S.A. 57 5 (1967) 1275-1279
18. Jansen B.A.J., Brouwer J., and Reedijk J. Glutathione Induces Cellular Resistance Against Cationic Dinuclear Platinum Anticancer Drugs. J. Inorg. Biochem. 89 3/4 (2002) 197-202
19. Ghezzi A., Aceto M., Cassino C., Gabano E., and Osella D. Uptake of Antitumor Platinum(II)-Complexes by Cancer Cells, Assayed by Inductively Coupled Plasma Mass Spectrometry (ICP-MS). J. Inorg. Biochem. 98 1 (2004) 73-78
20. Wang D., and Lippard S.J. Cellular Processing of Platinum Anticancer Drugs. Nat. Rev. Drug Discov. 4 4 (2005) 307-320
21. Fichtinger-Schepman A.M.J., Vanderveer J.L., Denhartog J.H.J., Lohman P.H.M., and Reedijk J. Adducts of the Antitumor Drug Cis-Diamminedichloroplatinum(II) with DNA-Formation, Identification, and Quantitation. Biochemistry 24 3 (1985) 707-713
22. Bosl G.J., and Motzer R.J. Testicular Germ-Cell Cancer. New Engl. J. Med. 337 4 (1997) 242-254
23. McGowan G., Parsons S., and Sadler P.J. Contrasting Chemistry of Cis- and Trans-Platinum(II) Diamine Anticancer Compounds: Hydrolysis Studies of Picoline Complexes. Inorg. Chem. 44 21 (2005) 7459-7467
24. Eastman A. Reevaluation of Interaction of Cis-Dichloro(Ethylenediamine)Platinum(II) with DNA. Biochemistry 25 13 (1986) 3912-3915
25. Fichtinger-Schepman A.M.J., Vanoosterom A.T., Lohman P.H.M., and Berends F. Cis-Diamminedichloroplatinum(II)-Induced DNA Adducts in peripheral Leukocytes from 7 Cancer Patients-Quantitative Immunochemical Detection of the Adduct Induction and Removal after a Single Dose of Cis-Diamminedichloroplatinum(II). Cancer Res. 47 11 (1987) 3000-3004
26. Poirier M.C., Reed E., Zwelling L.A., Ozols R.F., Litterst C.L., and Yuspa S.H. Polyclonal Antibodies to Quantitate Cis-Diamminedichloroplatinum(II)-DNA Adducts in Cancer Patients and Anima -Models. Environ. Health Perspect. 62 10 (1985) 89-94
27. Reed E., Ozols R.F., Tarone R., Yuspa S.H., and Poirier M.C. Platinum-DNA Adducts in Leukocyte DNA Correlate with Disease Response in Ovarian-Cancer Patients Receiving Platinum-Based Chemotherapy. Proc. Natl. Acad. Sci. U.S.A. 84 14 (1987) 5024-5028
28. Reed E., Yuspa S.H., Zwelling L.A., Ozols R.F., and Poirier M.C. Quantitation of Cis-Diamminedichloroplatinum-II (Cisplatin)-DNA-Intrastrand Adducts in Testicular and Ovarian-Cancer Patients Receiving Cisplatin Chemotherapy. J. Clin. Investig. 77 2 (1986) 545-550
29. Admiraal G., Vanderveer J.L., Degraaff R.A.G., Denhartog J.H.J., and Reedijk J. Intrastrand Bis(Guanine) Chelation of D(CpGpG) to Cisplatinum-an X-Ray Single-Crystal Structure Analysis. J. Am. Chem. Soc. 109 2 (1987) 592-594
30. Yang D.Z., Vanboom S., Reedijk J., Vanboom J.H., and Wang A.H.J. Structure and Isomerization of an Intrastrand Cisplatin-Cross-Linked Octamer DNA Duplex by NMR Analysis. Biochemistry 34 39 (1995) 12912-12920
31. Harder H.C., Smith R.G., and Leroy A.F. Template Primer Inactivation by Cis-Dichlorodiamine and Trans-Dichlorodiamine Platinum for Human DNA-Polymerase α, β, and Rauscher Murine Leukemia-Virus Reverse-Transcriptase, as a Mechanism of Cytotoxicity. Cancer Res. 36 10 (1976) 3821-3829
32. Hoffmann J.S., Johnson N.P., and Villani G. Conversion of Monofunctional DNA Adducts of Cis-Diamminedichloroplatinum(II) to Bifunctional Lesions-Effect on the In Vitro Replication of Single-Stranded-DNA by Escherichia coli DNA-Polymerase-I and Eukaryotic DNA Polymerases-α. J. Biol. Chem. 264 25 (1989) 15130-15135
33. Johnson N.P., Hoeschele J.D., Kuemmerle N.B., Masker W.E., and Rahn R.O. Effects of Platinum Anti-Tumor Agents and Pyrimidine Dimers on In Vitro Replication of T7-DNA. Chem. Biol. Interact. 23 2 (1978) 267-271
34. Pinto A.L., and Lippard S.J. Sequence-Dependent Termination of In Vitro DNA-Synthesis by Cis-Diamminedichloroplatinum(II) and Trans-Diamminedichloroplatinum(II). Proc. Natl. Acad. Sci. U.S.A. 82 14 (1985) 4616-4619
35. Villani G., Hubscher U., and Butour J.L. Sites of Termination of In Vitro DNA-Synthesis on Cis-Diamminedichloroplatinum(Ii) Treated Single-Stranded-DNA-a Comparison Between Escherichia coli DNA-Polymerase-I and Eukaryotic DNA Polymerases-α. Nucleic Acids Res. 16 10 (1988) 4407-4418
36. Corda Y., Job C., Anin M.F., Leng M., and Job D. Transcription by Eukaryotic and Prokaryotic RNA-Polymerases of DNA Modified at a D(GG) or a D(AG) Site by the Antitumor Drug Cis-Diamminedichloroplatinum(II). Biochemistry 30 1 (1991) 222-230
37. Cullinane C., Mazur S.J., Essigmann J.M., Phillips D.R., and Bohr V.A. Inhibition of RNA Polymerase II Transcription in Human Cell Extracts by Cisplatin DNA Damage. Biochemistry 38 19 (1999) 6204-6212
38. Lemaire M.A., Schwartz A., Rahmouni A.R., and Leng M. Interstrand Cross-Links are Preferentially Formed at the D(GC) Sites in the Reaction Between Cis-Diamminedichloroplatinum(Ii) and DNA. Proc. Natl. Acad. Sci. U.S.A. 88 5 (1991) 1982-1985
39. Sorenson C.M., and Eastman A. Mechanism of Cis-Diamminedichloroplatinum(II)-induced Cytotoxicity-Role of G2 Arrest and DNA Double-Strand Breaks. Cancer Res. 48 16 (1988) 4484-4488
40. Gonnet F., Kocher F., Blais J.C., Bolbach G., Tabet J.C., and Chottard J.C. Kinetic Analysis of the Reaction Between d(TTGGCCAA) and [Pt(NH3)(3)(H2O)](2+) by Enzymatic Degradation of the Products and ESI and MALDI Mass Spectrometries. J. Mass Spectrom. 31 7 (1996) 802-809
41. Marchan V., Moreno V., Pedroso E., and Grandas A. Towards a Better Understanding of the Cisplatin Mode of Action. Chem. A Eur. J. 7 4 (2001) 808-815
42. Meczes E.L., Azim-Araghi A., Ottley C.J., Pearson D.G., and Tilby M.J. Specific Adducts Recognized by a Monoclonal Antibody Against Cisplatin-Modified DNA. Biochem. Pharmacol. 70 12 (2005) 1717-1725
43. Troujman H., and Chottard J.C. Comparison between HPLC and Capillary Electrophoresis for the Separation and Identification of the Platination Products of Oligonucleotides with Cis-[Pt(NH3)(2)(H2O)(2)](2+). Anal. Biochem. 252 1 (1997) 177-185
44. Grotjahn L., Frank R., and Blocker H. Ultrafast Sequencing of Oligodeoxyribonucleotides by FAB-Mass Spectrometry. Nucleic Acids Res. 10 15 (1982) 4671-4678
45. Sindona G., Uccella N., and Weclawek K. Structure Determination of Isomeric Oligodeoxynucleotide Salts by Fast-Atom-Bombardment Mass-Spectrometry. J. Chem. Res. S (1982) 184-185
46. Panico M., Sindona G., and Uccella N. Bioorganic Applications of Mass Spectrometry. 3. Fast-Atom-Bombardment-Induced Zwitterionic Oligonucleotide Quasimolecular Ions Sequenced by MS/MS. J. Am. Chem. Soc. 105 17 (1983) 5607-5610
47. Cerny R.L., Gross M.L., and Grotjahn L. Fast-Atom-Bombardment Combined with Tandem Mass-Spectrometry for the Study of Dinucleotides. Anal. Biochem. 156 2 (1986) 424-435
48. Wang Z., Wan K.X., Ramanathan R., Taylor J.S., and Gross M.L. Structure and Fragmentation Mechanisms of Isomeric T-Rich Oligodeoxynucleotides: A Comparison of Four Tandem Mass Spectrometric Methods. J. Am. Soc. Mass Spectrom. 9 7 (1998) 683-691
49. Wan K.X., Gross J., Hillenkamp F., and Gross M.L. Fragmentation Mechanisms of Oligodeoxynucleotides Studied by H/D Exchange and Electrospray Ionization Tandem Mass Spectrometry. J. Am. Soc. Mass Spectrom. 12 2 (2001) 193-205
50. Wan K.X., and Gross M.L. Fragmentation Mechanisms of Oligodeoxynucleotides: Effects of Replacing Phosphates with Methylphosphonates and Thymines with Other Bases in T-Rich Sequences. J. Am. Soc. Mass Spectrom. 12 5 (2001) 580-589
51. Cerny R.L., Tomer K.B., Gross M.L., and Grotjahn L. Fast-Atom-Bombardment Combined with Tandem Mass-Spectrometry for Determining Structures of Small Oligonucleotides. Anal. Biochem. 165 1 (1987) 175-182
52. Schürch S., Bernal-Mendez E., and Leumann C.J. Electrospray Tandem Mass Spectrometry of Mixed-Sequence RNA/DNA Oligonucleotides. J. Am. Soc. Mass Spectrom. 13 8 (2002) 936-945
53. Tromp J.M., and Schürch S. Gas-Phase Dissociation of Oligoribonucleotides and Their Analogs Studied by Electrospray Ionization Tandem Mass Spectrometry. J. Am. Soc. Mass Spectrom. 16 8 (2005) 1262-1268
54. Andersen T.E., Kirpekar F., and Haselmann K.F. RNA Fragmentation in MALDI Mass Spectrometry Studied by H/D-Exchange: Mechanisms of General Applicability to Nucleic Acids. J. Am. Soc. Mass Spectrom. 17 10 (2006) 1353-1368
55. Puzo G., Prome J.C., Macquet J.P., and Lewis I.A.S. Fast Atom Bombardment Mass-Spectra of the Bis-Guanosine Adduct with Cisplatin. Biomed. Mass Spectrom. 9 12 (1982) 552-556
56. Roos I.A.G., Thomson A.J., and Eagles J. Mass-Spectrometric Studies of Interaction of Platinum Complexes with Nucleoside Analogs. Chem. Biol. Interact. 8 6 (1974) 421-427
57. Hunt D.F., Hignite C.E., and Biemann K. Structure Elucidation of Dinucleotides by Mass Spectrometry. Biochem. Biophys. Res. Commun. 33 3 (1968) 378-383
58. McCloskey J.A., Lawson A.M., Tsuboyama K., Krueger P.M., and Stillwell R.N. Mass Spectrometry of Nucleic Acid Components. Trimethylsilyl Derivatives of Nucleotides, Nucleosides, and Bases. J. Am. Chem. Soc. 90 15 (1968) 4182-4184
59. Macquet J.P., Jankowski K., and Butour J.L. Mass-Spectrometry Study of DNA-Cisplatin Complexes-Pertubation of Guanine-Cytosine Base Pairs. Biochem. Biophys. Res. Commun. 92 1 (1980) 68-74
60. Claereboudt J., Despiegeleer B., Debruijn E.A., Gijbels R., and Claeys M. Structural Characterizations of Cisplatin Analogs by Fast Atom Bombardment (FAB) and Laser Microprobe Mass-Spectrometry (LAMMA). J. Pharm. Biomed. Anal. 7 12 (1989) 1599-1610
61. Martin L.B., Schreiner A.F., and Vanbreemen R.B. Characterization of Cisplatin Adducts of Oligonucleotides by Fast-Atom-Bombardment Mass-Spectrometry. Anal. Biochem. 193 1 (1991) 6-15
62. Costello C.E., Comess K.M., Plaziak A.S., Bancroft D.P., and Lippard S.J. Fast-Atom-Bombardment and High-Performance Tandem Mass-Spectrometry Of Platinum(II) Oligodeoxyribonucleotide Fragments. Int. J. Mass Spectrom. Ion Processes 122 (1992) 255-279
63. Baik M.H., Friesner R.A., and Lippard S.J. Theoretical Study on the Stability of N-Glycosyl Bonds: Why Does N7-Platination not Promote Depurination?. J. Am. Chem. Soc. 124 16 (2002) 4495-4503
64. Iannitti-Tito P., Weimann A., Wickham G., and Sheil M.M. Structural Analysis of Drug-DNA Adducts by Tandem Mass Spectrometry. Analyst 125 4 (2000) 627-633
65. Zhang Q.R., Yu E.T., Kellersberger K.A., Crosland E., and Fabris D. Toward Building a Database of Bifunctional Probes for the MS3D Investigation of Nucleic Acids Structures. J. Am. Soc. Mass Spectrom. 17 11 (2006) 1570-1581
66. Iannitti P., Sheil M.M., and Wickham G. High Sensitivity and Fragmentation Specificity in the Analysis of Drug-DNA Adducts by Electrospray Tandem Mass Spectrometry. J. Am. Chem. Soc. 119 6 (1997) 1490-1491
67. Barry J.P., Vouros P., Vanschepdael A., and Law S.J. Mass and Sequence Verification of Modified Oligonucleotides Using Electrospray Tandem Mass Spectrometry. J. Mass Spectrom. 30 7 (1995) 993-1006
68. Marzilli L.A., Barry J.P., Sells T., Law S.J., Vouros P., and Harsch A. Oligonucleotide Sequencing Using Guanine-Specific Methylation and Electrospray Ionization Ion Trap Mass Spectrometry. J. Mass Spectrom. 34 4 (1999) 276-280
69. Kirpekar F., Nordhoff E., Kristiansen K., Roepstorff P., Hahner S., and Hillenkamp F. 7-Deaza Purine Bases Offer a Higher Ion Stability in the Analysis of DNA by Matrix-Assisted Laser Desorption/Iionization Mass Spectrometry. Rapid Commun. Mass Spectrom. 9 6 (1995) 525-531
70. Carsey T.P., and Boudreaux E.A. The Electronic Structure of Platinum-Guanine Complexes. Chem. Biol. Interact. 30 2 (1980) 189-201
71. Monn S.T.M., and Schürch S. New Aspects of the Fragmentation Mechanisms of Unmodified and Methylphosphonate-Modified Oligonucleotides. J. Am. Soc. Mass Spectrom. 18 6 (2007) 984-990